Natriuretic Peptides Attenuate Retinal Pathological Neovascularization Via Cyclic Guanosine Monophosphate Signaling in Pericytes and Astrocytes
Authors:
- 1 January 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 40 (1) , 159-174
Abstract
Objective: In proliferative retinopathies, complications derived from neovascularization cause blindness. During early disease, pericyte’s apoptosis contributes to endothelial dysfunction and leakage. Hypoxia then drives VEGF (vascular endothelial growth factor) secretion and pathological neoangiogenesis. Cardiac ANP (atrial natriuretic peptide) contributes to systemic microcirculatory homeostasis. ANP is also formed in the retina, with unclear functions. Here, we characterized whether endogenously formed ANP regulates retinal (neo)angiogenesis. Approach and Results: Retinal vascular development and ischemia-driven neovascularization were studied in mice with global deletion of GC-A (guanylyl cyclase-A), the cGMP (cyclic guanosine monophosphate)-forming ANP receptor. Mice with a floxed GC-A gene were interbred with Tie2-Cre, GFAP-Cre, or PDGF-Rβ-Cre ERT2 lines to dissect the endothelial, astrocyte versus pericyte-mediated actions of ANP in vivo. In neonates with global GC-A deletion (KO), vascular development was mildly delayed. Moreover, such KO mice showed augmented vascular regression and exacerbated ischemia-driven neovascularization in the model of oxygen-induced retinopathy. Notably, absence of GC-A in endothelial cells did not impact retinal vascular development or pathological neovascularization. In vitro ANP/GC-A/cGMP signaling, via activation of cGMP-dependent protein kinase I, inhibited hypoxia-driven astrocyte’s VEGF secretion and TGF-β (transforming growth factor beta)–induced pericyte apoptosis. In neonates lacking ANP/GC-A signaling in astrocytes, vascular development and hyperoxia-driven vascular regression were unaltered; ischemia-induced neovascularization was modestly increased. Remarkably, inactivation of GC-A in pericytes retarded physiological retinal vascularization and markedly enhanced cell apoptosis, vascular regression, and subsequent neovascularization in oxygen-induced retinopathy. Conclusions: Protective pericyte effects of the ANP/GC-A/cGMP pathway counterregulate the initiation and progression of experimental proliferative retinopathy. Our observations indicate augmentation of endogenous pericyte ANP signaling as target for treatment of retinopathies associated with neovascularization.Keywords
This publication has 37 references indexed in Scilit:
- Retinal vasculature development in health and diseaseProgress in Retinal and Eye Research, 2018
- Pathophysiology of Diabetic Retinopathy: The Old and the NewDiabetes & Metabolism Journal, 2018
- Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implicationsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2016
- Molecular Physiology of Membrane Guanylyl Cyclase ReceptorsPhysiological Reviews, 2016
- Pathophysiology and Mechanisms of Severe Retinopathy of PrematurityOphthalmology, 2015
- Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of lifeJournal of Clinical Investigation, 2010
- Atrial Natriuretic Peptide Reduces Vascular Leakage and Choroidal NeovascularizationThe American Journal of Pathology, 2009
- Diabetic RetinopathyNew England Journal of Medicine, 2004
- Pericytes and the Pathogenesis of Diabetic RetinopathyDiabetes, 2002
- Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptideNature, 1995